Annual report pursuant to Section 13 and 15(d)

Note 12 - Segment Information - Financial Information Relating to Reportable Segments (Details)

v3.20.2
Note 12 - Segment Information - Financial Information Relating to Reportable Segments (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Revenues, net $ 738,691 $ 714,006 $ 642,993
Operating income 157,419 146,719 136,178
Costs recognized upon sale of acquired inventory 0 (3,739) (2,455)
Gain on escrow settlement 7,170 (0) (0)
Corporate general, selling and administrative expenses (260,583) (264,359) (240,636)
Total long-lived assets 176,829 154,039  
Total intangible assets 516,545 579,429 446,332
United States and Canada [Member]      
Total long-lived assets 162,039 138,016  
Total intangible assets 499,875 556,951  
Europe [Member]      
Total long-lived assets 13,120 14,439  
Total intangible assets 12,349 16,637  
Asia [Member]      
Total long-lived assets 1,670 1,584  
Total intangible assets 4,321 5,841  
Consumables [Member]      
Revenues, net 602,642 588,979 534,738
Protein Sciences [Member] | Consumables [Member]      
Revenues, net 431,052 430,655 384,350
Diagnostics and Genomics [Member] | Consumables [Member]      
Revenues, net 171,590 158,324 150,388
Operating Segments [Member]      
Operating income 249,894 250,998 245,376
Costs recognized upon sale of acquired inventory 0 (3,739) (2,455)
Amortization of acquired intangible assets (60,865) (58,550) (46,983)
Gain on escrow settlement 7,169 0 0
Acquisition related expenses (416) (2,282) (24,429)
Restructuring costs (87) 0 (376)
Stock-based compensation (34,262) (33,057) (28,240)
Operating Segments [Member] | Protein Sciences [Member]      
Revenues, net 555,352 543,159 482,378
Operating income 234,929 240,919 209,880
Operating Segments [Member] | Diagnostics and Genomics [Member]      
Revenues, net 184,549 171,674 161,151
Operating income 14,965 10,079 35,496
Intersegment Eliminations [Member]      
Revenues, net (1,210) (827) (536)
Corporate, Non-Segment [Member]      
Corporate general, selling and administrative expenses $ (4,015) $ (6,651) $ (6,715)